New York, NY -- (SBWIRE) -- 12/17/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Alpha Natural Resources, Inc (NYSE:ANR), Kinross Gold Corporation (USA) (NYSE:KGC), Zynga Inc (NASDAQ:ZNGA), CytRx Corporation (NASDAQ:CYTR)
Alpha Natural Resources, Inc (NYSE:ANR) the stock opened the session at $6.35 but then moved to $6.33. At that price, the stock showed a positive performance of 0.16%. Alpha Natural Resources, Inc. (Alpha) is a supplier and exporter of metallurgical coals for use in the steel-making process and a supplier of thermal coal to electric utilities and manufacturing industries, as well as a exporter of thermal coal. As of December 31, 2012, the Company operated 107 mines and 26 coal preparation plants in Northern and Central Appalachia and the Powder River Basin.
Will ANR Continue To Move Higher? Find Out Here
Kinross Gold Corporation (USA) (NYSE:KGC) opened the session at $4.61 and closed the session at $4.63. The stock showed a positive performance of 0.87% in previous trading session. Kinross Gold Corporation (Kinross) is engaged in gold mining and related activities, including exploration and acquisition of gold-bearing properties, the extraction and processing of gold-containing ore, and reclamation of gold mining properties. Kinross also produces and sells silver.
For How Long KGC will fight for Profitability? Read This Trend Analysis report
Zynga Inc (NASDAQ:ZNGA) opened the session at $4.11 and closed the session at $4.10. The beta of the stock remained 0.01. Zynga Inc. (Zynga) is the provider of social game services. The Company develops , market and operates online social games as live services played over the Internet and on social networking sites and mobile platforms. The Company's games are accessible on Facebook and other social networks, mobile platforms and Zynga.com. According to AppData, as of December 31, 2012,
Is ZNGA a Solid Investment at These Levels? Read This Report For Details
CytRx Corporation (NASDAQ:CYTR) traded with volume of 9.65 million shares in the prior session and the average volume of the stock remained 3.60 million shares. The beta of the stock remained 1.21. CytRx Corporation (CytRx) is a biopharmaceutical research and development company specializing in oncology. The Company's oncology pipeline includes three programs in clinical development for cancer indications: INNO-206, tamibarotene and bafetinib. INNO-206 is the Company's tumor-targeted doxorubicin conjugate. On May 13, 2011, the Company sold all pre-clinical and clinical data, intellectual property rights and other assets relating to those compounds to Orphazyme ApS.
Is CYTR a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)